NCT03607760 is a clinical trial of ECMO in Extracorporeal Membrane Oxygenation, sponsored by Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.

What drugs are being tested in NCT03607760?

Interventions in NCT03607760: ECMO, conventional mechanical ventilation.

What condition does NCT03607760 study?

NCT03607760 studies Extracorporeal Membrane Oxygenation.

Is NCT03607760 still recruiting?

NCT03607760 is currently completed. Last updated 10 April 2019.

Last reviewed 2019-04-10 · How we verify

NCT03607760

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Extracorporeal Membrane Oxygenation (ECMO)

Completed Last updated 10 April 2019

What this trial tests

trial testing ECMO in Extracorporeal Membrane Oxygenation in 300 participants. Completed in 4 April 2019.

Timeline

11 November 2018

Primary endpoint
1 March 2019

4 April 2019

Quick facts

Lead sponsor	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	300
Start date	11 November 2018
Primary completion	1 March 2019
Estimated completion	4 April 2019
Sites	1 location across China

Drugs / interventions tested

ECMO
conventional mechanical ventilation

Conditions studied

Extracorporeal Membrane Oxygenation — all drugs for Extracorporeal Membrane Oxygenation →

Sponsor

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Who can join

Adults 1 Hour to 1 Month, any sex, with Extracorporeal Membrane Oxygenation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Since the 1970s, extracorporeal membrane oxygenation (ECMO) support has been used to support gas exchange for children with severe acute respiratory failure who fail mechanical ventilation. ECMO is more expensive than each of these other procedures.But its action is unclear

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The value of oxygen index and base excess in predicting the outcome of neonatal acute respiratory distress syndrome.
Wu H, Hong X, Qu Y, Liu Z, et al · · 2021 · cited 12× · PMID 32822669 · DOI 10.1016/j.jped.2020.07.005
Venoarterial Extracorporeal Membrane Oxygenation for Severe Neonatal Acute Respiratory Distress Syndrome in a Developing Country.
Hong X, Zhao Z, Liu Z, Liu C, et al · · 2020 · cited 3× · PMID 32548079 · DOI 10.3389/fped.2020.00227

Verify or expand the search:

Other trials of ECMO

Trials testing the same drug.

NCT05730881 — Comparison of Four Intensive Care Scores in Prediction of VA-ECMO Survival. · unknown
NCT05158816 — Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19 · completed
NCT04709432 — ECMO Treatment of Children in China in the Past 10 Years · recruiting
NCT03948048 — Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock · recruiting
NCT03662594 — Growth of High-Quality Oxides on The Inner Surface of ECMO Circuit by ALD to Reduce Thrombus Formation · NA · completed

Other recruiting trials for Extracorporeal Membrane Oxygenation

Currently open trials in the same condition.

NCT06862700 — Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients · recruiting
NCT06560164 — Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO · NA · recruiting
NCT06369584 — Prone Position During ECMO in Pediatric Patients With Severe ARDS · NA · recruiting
NCT05574296 — Hydrogen's Feasibility and Safety as a Therapy in ECPR · Phase 1 · recruiting
NCT06660784 — Mechanism of Nitric Oxide on Ventilator-induced Diaphragm Dysfunction with Extracorporeal Membrane Lung Assistance · active not recruiting

Other Daping Hospital and the Research Institute of Surgery of the Third Military Medical University trials

Trials by the same sponsor.

NCT07468630 — Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma · Phase 2 · recruiting
NCT07467590 — Combination of High and Low-Dose Radiotherapy With Immune Therapy and TKI in Advanced Colorectal Cancer: A Phase II Stud · Phase 2 · not yet recruiting
NCT07459192 — Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors · not yet recruiting
NCT07459179 — Clinical Study on the Application of PET Probes Targeting DDR2 in the Diagnosis of Interstitial Lung Disease With Cognit · not yet recruiting
NCT07459205 — Clinical Application of 68Ga-1A12 PET in Fibrosis-related Diseases · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03607760 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Last refreshed: 10 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03607760.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing